aprocitentan
Apr 08, 2024
Idorsia’s Tryvio Success in Hypertension Treatment After J&J ‘Blunder’?
After Johnson & Johnson reversed its decision last year regarding the acquisition of Tryvio (aprocitentan) in 2017, the original manufacturer of the hypertension treatment drug, Idorsia Pharmaceuticals has successfully guided the drug through the FDA approval process. The company stated that Tryvio, its endo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
